D. Textarchiv--altmann and R. , Ueber die Beziehungen zwischen Phloridzin und Salicin und ihre Zusammensetzung., Archiv der Pharmazie, vol.73, issue.2, pp.199-202, 1840.

T. G. Frey and C. A. Mannella, The internal structure of mitochondria, Trends in Biochemical Sciences, vol.25, issue.7, pp.319-324, 2000.

G. E. Palade, The fine structure of mitochondria, The Anatomical Record, vol.114, issue.3, pp.427-451, 1952.

F. S. Sjostrand, Electron Microscopy of Mitochondria and Cytoplasmic Double Membranes: Ultra-Structure of Rod-shaped Mitochondria, Nature, vol.171, issue.4340, pp.30-31, 1953.

S. G. Andersson, A. Zomorodipour, J. O. Andersson, T. Sicheritz-pontén, U. C. Alsmark et al., The genome sequence of Rickettsia prowazekii and the origin of mitochondria, Nature, vol.396, issue.6707, pp.133-140, 1998.

A. Claude, FRACTIONATION OF MAMMALIAN LIVER CELLS BY DIFFERENTIAL CENTRIFUGATION: I. PROBLEMS, METHODS, AND PREPARATION OF EXTRACT, Journal of Experimental Medicine, vol.84, issue.1, pp.51-59, 1946.

R. R. Bensley, On the nature of the pigment of mitochondria and of submicroscopic particles in the hepatic cell of the guinea pig, The Anatomical Record, vol.98, issue.4, pp.609-619, 1947.

D. Keilin and W. B. Hardy, On cytochrome, a respiratory pigment, common to animals, yeast, and higher plants, Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character, vol.98, issue.690, pp.312-339, 1925.

E. P. Kennedy and A. L. Lehninger, Oxidation of fatty acids and tricarboxylic acid cycle intermediates by isolated rat liver mitochondria, J. Biol. Chem, vol.179, pp.957-972, 1949.

A. L. Lehninger, C. S. Rossi, and J. W. Greenawalt, Respiration-dependent accumulation of inorganic phosphate and Ca++ by rat liver mitochondria, Biochemical and Biophysical Research Communications, vol.10, issue.6, pp.444-448, 1963.

L. Ernster and G. Schatz, Mitochondria: a historical review., Journal of Cell Biology, vol.91, issue.3, pp.227s-255s, 1981.

P. Mitchell, Coupling of Phosphorylation to Electron and Hydrogen Transfer by a Chemi-Osmotic type of Mechanism, Nature, vol.191, issue.4784, pp.144-148, 1961.

S. Anderson, A. T. Bankier, B. G. Barrell, M. H. De-bruijn, A. R. Coulson et al., Sequence and organization of the human mitochondrial genome, Nature, vol.290, issue.5806, pp.457-465, 1981.

K. S. Dimmer and L. Scorrano, (De)constructing Mitochondria: What For?, Physiology, vol.21, issue.4, pp.233-241, 2006.

G. Lenaz, Mitochondria and Reactive Oxygen Species. Which Role in Physiology and Pathology?, Advances in Experimental Medicine and Biology, vol.942, pp.93-136, 2011.

S. L. Spencer and P. K. Sorger, Papa S, Paradies G: On the mechanism of translocation of pyruvate and other monocarboxylic acids in rat-liver mitochondria, Rev. Physiol. Biochem. Pharmacol, vol.144, pp.757-785, 1983.

F. Emma, G. Montini, L. Salviati, and C. Dionisi-vici, Renal Mitochondrial Cytopathies, International Journal of Nephrology, vol.2011, pp.1-10, 2011.

J. M. Matés, C. Pérez-gómez, and I. N. De-castro, Antioxidant enzymes and human diseases, Clinical Biochemistry, vol.32, issue.8, pp.595-603, 1999.

G. Calabrese, B. Morgan, and J. Riemer, Mitochondrial Glutathione: Regulation and Functions, Antioxidants & Redox Signaling, vol.27, issue.15, pp.1162-1177, 2017.

, Correction to: Antioxid Redox Signal 2017; 27(7): 379?397. DOI: 10.1089/ars.2016.6642, Antioxidants & Redox Signaling, vol.27, issue.18, pp.1520-1520, 2017.

D. E. Handy, E. Lubos, Y. Yang, J. D. Galbraith, N. Kelly et al., Glutathione Peroxidase-1 Regulates Mitochondrial Function to Modulate Redox-dependent Cellular Responses, Journal of Biological Chemistry, vol.284, issue.18, pp.11913-11921, 2009.

R. Teruya, A. T. Ikejiri, F. Somaio-neto, J. C. Chaves, P. R. Bertoletto et al., Expression of oxidative stress and antioxidant defense genes in the kidney of inbred mice after intestinal ischemia and reperfusion, Acta Cirurgica Brasileira, vol.28, issue.12, pp.848-855, 2013.

M. D. Brand, C. Affourtit, T. C. Esteves, K. Green, A. J. Lambert et al., Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins, Free Radical Biology and Medicine, vol.37, issue.6, pp.755-767, 2004.

D. R. Green and G. Kroemer, The Pathophysiology of Mitochondrial Cell Death, Science, vol.305, issue.5684, pp.626-629, 2004.

D. R. Green and J. C. Reed, Mitochondria and apoptosis, vol.281, pp.1309-1312, 1998.

P. Bhargava and R. G. Schnellmann, Mitochondrial energetics in the kidney, Nature Reviews Nephrology, vol.13, issue.10, pp.629-646, 2017.

J. F. Kerr, A. H. Wyllie, and A. R. Currie, Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics, British Journal of Cancer, vol.26, issue.4, pp.239-257, 1972.

K. F. Ferri and G. Kroemer, Organelle-specific initiation of cell death pathways, Nature Cell Biology, vol.3, issue.11, pp.E255-E263, 2001.

J. M. Adams and S. Cory, Life-or-death decisions by the Bcl-2 protein family, Trends in Biochemical Sciences, vol.26, issue.1, pp.61-66, 2001.

M. Giacomello, I. Drago, P. Pizzo, and T. Pozzan, Mitochondrial Ca2+ as a key regulator of cell life and death, Cell Death & Differentiation, vol.14, issue.7, pp.1267-1274, 2007.

M. Crompton, The mitochondrial permeability transition pore and its role in cell death, Biochemical Journal, vol.341, issue.2, p.233, 1999.

M. Crompton, The mitochondrial permeability transition pore and its role in cell death, Biochemical Journal, vol.341, issue.2, pp.233-249, 1999.

S. A. Susin, H. K. Lorenzo, N. Zamzami, I. Marzo, B. E. Snow et al., Molecular characterization of mitochondrial apoptosis-inducing factor, Nature, vol.397, issue.6718, pp.441-446, 1999.

X. Liu, C. N. Kim, J. Yang, R. Jemmerson, and X. Wang, Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c, Cell, vol.86, issue.1, pp.147-157, 1996.

B. Baliga and S. Kumar, Apaf-1/cytochrome c apoptosome: an essential initiatorof caspase activation or just a sideshow?, Cell Death & Differentiation, vol.10, issue.1, pp.16-18, 2003.

S. Jeong and D. Seol, The role of mitochondria in apoptosis, BMB Reports, vol.41, issue.1, pp.11-22, 2008.

J. N. Meyer, T. C. Leuthner, and A. L. Luz, Mitochondrial fusion, fission, and mitochondrial toxicity, Toxicology, vol.391, pp.42-53, 2017.

A. Pyle, G. Hudson, I. J. Wilson, J. Coxhead, T. Smertenko et al., Extreme-Depth Re-sequencing of Mitochondrial DNA Finds No Evidence of Paternal Transmission in Humans, PLOS Genetics, vol.11, issue.5, p.e1005040, 2015.

K. Khrapko, Two ways to make an mtDNA bottleneck, Nature Genetics, vol.40, issue.2, pp.134-135, 2008.

F. L. Marlow, Mitochondrial matters: Mitochondrial bottlenecks, self-assembling structures, and entrapment in the female germline, Stem Cell Research, vol.21, pp.178-186, 2017.

S. C. Sallevelt, C. E. De-die-smulders, A. T. Hendrickx, D. M. Hellebrekers, I. F. De-coo et al., De novo mtDNA point mutations are common and have a low recurrence risk, Journal of Medical Genetics, vol.54, issue.2, pp.73-83, 2016.

D. R. Thorburn, Mitochondrial disorders: Prevalence, myths and advances, Journal of Inherited Metabolic Disease, vol.27, issue.3, pp.349-362, 2004.

W. M. Brown, M. George, and A. C. Wilson, Rapid evolution of animal mitochondrial DNA., Proceedings of the National Academy of Sciences, vol.76, issue.4, pp.1967-1971, 1979.

A. Munnich, P. Rustin, A. Rötig, D. Chretien, J. P. Bonnefont et al., Clinical aspects of mitochondrial disorders, Journal of Inherited Metabolic Disease, vol.15, issue.4, pp.448-455, 1992.

G. S. Gorman, A. M. Schaefer, Y. Ng, N. Gomez, E. L. Blakely et al., Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease, Annals of Neurology, vol.77, issue.5, pp.753-759, 2015.

S. E. Calvo and V. K. Mootha, The Mitochondrial Proteome and Human Disease, Annual Review of Genomics and Human Genetics, vol.11, issue.1, pp.25-44, 2010.

G. Attardi and G. Schatz, Biogenesis of Mitochondria, Annual Review of Cell Biology, vol.4, issue.1, pp.289-331, 1988.

D. Ghezzi and M. Zeviani, Assembly Factors of Human Mitochondrial Respiratory Chain Complexes: Physiology and Pathophysiology, Advances in Experimental Medicine and Biology, vol.748, pp.65-106, 2012.

M. Doimo, M. A. Desbats, C. Cerqua, M. Cassina, E. Trevisson et al., Genetics of Coenzyme Q10 Deficiency, Molecular Syndromology, vol.5, issue.3-4, pp.156-162, 2014.

S. Dimauro, E. A. Schon, V. Carelli, and M. Hirano, The clinical maze of mitochondrial neurology, Nature Reviews Neurology, vol.9, issue.8, pp.429-444, 2013.

F. Emma, G. Montini, S. M. Parikh, and L. Salviati, Mitochondrial dysfunction in inherited renal disease and acute kidney injury, Nature Reviews Nephrology, vol.12, issue.5, pp.267-280, 2016.

P. M. O'connor, RENAL OXYGEN DELIVERY: MATCHING DELIVERY TO METABOLIC DEMAND, Clinical and Experimental Pharmacology and Physiology, vol.33, issue.10, pp.961-967, 2006.

Z. Wang, Z. Ying, A. Bosy-westphal, J. Zhang, B. Schautz et al., Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure, The American Journal of Clinical Nutrition, vol.92, issue.6, pp.1369-1377, 2010.

J. B. Lee, V. K. Vance, and G. F. Cahill, Metabolism of C14-labeled substrates by rabbit kidney cortex and medulla, American Journal of Physiology-Legacy Content, vol.203, issue.1, pp.27-36, 1962.

J. A. Jefferson, C. E. Alpers, and S. J. Shankland, Podocyte Biology for the Bedside, American Journal of Kidney Diseases, vol.58, issue.5, pp.835-845, 2011.

N. Endlich and K. Endlich, Stretch, tension and adhesion ? Adaptive mechanisms of the actin cytoskeleton in podocytes, European Journal of Cell Biology, vol.85, issue.3-4, pp.229-234, 2006.

C. Rigothier, P. Auguste, G. I. Welsh, S. I. Lepreux, C. Deminière et al., IQGAP1 Interacts with Components of the Slit Diaphragm Complex in Podocytes and Is Involved in Podocyte Migration and Permeability In Vitro, PLoS ONE, vol.7, issue.5, p.e37695, 2012.

K. Tryggvason and J. Wartiovaara, Molecular basis of glomerular permselectivity, Current Opinion in Nephrology and Hypertension, vol.10, issue.4, pp.543-549, 2001.

T. Imasawa and R. Rossignol, Podocyte energy metabolism and glomerular diseases, The International Journal of Biochemistry & Cell Biology, vol.45, issue.9, pp.2109-2118, 2013.

R. J. Coward, G. I. Welsh, J. Yang, C. Tasman, R. Lennon et al., The Human Glomerular Podocyte Is a Novel Target for Insulin Action, Diabetes, vol.54, issue.11, pp.3095-3102, 2005.

Y. Sekine, Y. Nishibori, Y. Akimoto, A. Kudo, N. Ito et al., Amino Acid Transporter LAT3 Is Required for Podocyte Development and Function, Journal of the American Society of Nephrology, vol.20, issue.7, pp.1586-1596, 2009.

C. Mayrhofer, S. Krieger, N. Huttary, M. Chang, J. Grillari et al., Alterations in Fatty Acid Utilization and an Impaired Antioxidant Defense Mechanism Are Early Events in Podocyte Injury, The American Journal of Pathology, vol.174, issue.4, pp.1191-1202, 2009.

Y. Abe, T. Sakairi, H. Kajiyama, S. Shrivastav, C. Beeson et al., Bioenergetic characterization of mouse podocytes, American Journal of Physiology-Cell Physiology, vol.299, issue.2, pp.C464-C476, 2010.

S. Ozawa, S. Ueda, H. Imamura, K. Mori, K. Asanuma et al., Glycolysis, but not Mitochondria, responsible for intracellular ATP distribution in cortical area of podocytes, Scientific Reports, vol.5, issue.1, p.18575, 2015.

N. Stieger, K. Worthmann, B. Teng, S. Engeli, A. M. Das et al., Impact of high glucose and transforming growth factor?? on bioenergetic profiles in podocytes, Metabolism, vol.61, issue.8, pp.1073-1086, 2012.

S. Sato, A. Adachi, Y. Sasaki, and W. Dai, Autophagy by Podocytes in Renal Biopsy Specimens, Journal of Nippon Medical School, vol.73, issue.2, pp.52-53, 2006.

B. Hartleben, M. Gödel, C. Meyer-schwesinger, S. Liu, T. Ulrich et al., Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice, Journal of Clinical Investigation, vol.120, issue.4, pp.1084-1096, 2010.

O. M. Sejersted, P. A. Steen, and F. Kiil, Energetics of tubular sodium reabsorption sensitive to ethacrynic acid and ouabain, American Journal of Physiology-Renal Physiology, vol.242, issue.3, pp.F254-F260, 1982.

S. C. Cramer, W. M. Pardridge, B. A. Hirayama, and E. M. Wright, Colocalization of GLUT2 glucose transporter, sodium/glucose cotransporter, and gamma-glutamyl transpeptidase in rat kidney with double-peroxidase immunocytochemistry, Diabetes, vol.41, issue.6, pp.766-770, 1992.

X. Yang, D. M. Okamura, X. Lu, Y. Chen, J. Moorhead et al., CD36 in chronic kidney disease: novel insights and therapeutic opportunities, Nature Reviews Nephrology, vol.13, issue.12, pp.769-781, 2017.

E. Fernández, D. Torrents, J. Chillarón, M. Del-río, R. Zorzano et al., Basolateral LAT-2 Has a Major Role in the Transepithelial Flux of L-Cystine in the Renal Proximal Tubule Cell Line OK, Journal of the American Society of Nephrology, vol.14, issue.4, pp.837-847, 2003.

S. Bagnasco, D. Good, R. Balaban, and M. Burg, Lactate production in isolated segments of the rat nephron, American Journal of Physiology-Renal Physiology, vol.248, issue.4, pp.F522-F526, 1985.

G. Wirthensohn and W. G. Guder, Renal substrate metabolism., Physiological Reviews, vol.66, issue.2, pp.469-497, 1986.

W. Neuhofer and N. X. Beck, CELL SURVIVAL IN THE HOSTILE ENVIRONMENT OF THE RENAL MEDULLA, Annual Review of Physiology, vol.67, issue.1, pp.531-555, 2005.

G. Torelli, E. Milla, A. Faelli, and S. Costantini, Energy requirement for sodium reabsorption in the in vivo rabbit kidney, American Journal of Physiology-Legacy Content, vol.211, issue.3, pp.576-580, 1966.

D. Corà, A. Fusaro, M. Vidal, G. Calconi, and R. Zuin,

, Massachusetts Medical Society, New England Journal of Medicine, vol.274, issue.20, pp.1149-1149, 1966.

A. I. Katz, A. Doucet, and F. Morel, Na-K-ATPase activity along the rabbit, rat, and mouse nephron, American Journal of Physiology-Renal Physiology, vol.237, issue.2, pp.F114-F120, 1979.

W. G. Guder, S. Pürschel, and G. Wirthensohn, Renal Ketone Body Metabolism. Distribution of 3-Oxoacid CoA-Transferase and 3-Hydroxybutyrate Dehydrogenase along the Mouse Nephron, Hoppe-Seyler´s Zeitschrift für physiologische Chemie, vol.364, issue.2, pp.1727-1738, 1983.

M. Su, A. Dhoopun, Y. Yuan, S. Huang, C. Zhu et al., Mitochondrial dysfunction is an early event in aldosterone-induced podocyte injury, American Journal of Physiology-Renal Physiology, vol.305, issue.4, pp.F520-F531, 2013.

C. Zhu, S. Huang, Y. Yuan, G. Ding, R. Chen et al., Mitochondrial Dysfunction Mediates Aldosterone-Induced Podocyte Damage, The American Journal of Pathology, vol.178, issue.5, pp.2020-2031, 2011.

N. Lameire, W. Vanbiesen, and R. Vanholder, Acute renal failure, The Lancet, vol.365, issue.9457, pp.417-430, 2005.

D. P. Basile, M. D. Anderson, and T. A. Sutton, Pathophysiology of Acute Kidney Injury, Compr. Physiol, vol.2, pp.1303-1353, 2012.

J. A. Funk and R. G. Schnellmann, Persistent disruption of mitochondrial homeostasis after acute kidney injury, American Journal of Physiology-Renal Physiology, vol.302, issue.7, pp.F853-F864, 2012.

E. Ruidera, C. E. Irazu, P. R. Rajagopalan, J. K. Orak, C. T. Fitts et al., Fatty acid metabolism in renal ischemia, Lipids, vol.23, issue.9, pp.882-884, 1988.

A. L. Johnson, A. Stahl, and R. A. Zager, Triglyceride accumulation in injured renal tubular cells: Alterations in both synthetic and catabolic pathways, Kidney International, vol.67, issue.6, pp.2196-2209, 2005.

J. P. Idrovo, W. L. Yang, J. Nicastro, G. F. Coppa, and P. F. Wang, Stimulation of Carnitine Palmitoyltransferase 1 Improves Renal Function and Attenuates Tissue Damage After Ischemia/Reperfusion, Journal of Surgical Research, vol.172, issue.2, p.263, 2012.

R. A. Zager, A. C. Johnson, and S. Y. Hanson, Renal tubular triglyercide accumulation following endotoxic, toxic, and ischemic injury, Kidney International, vol.67, issue.1, pp.111-121, 2005.

N. Simon and A. Hertig, Alteration of Fatty Acid Oxidation in Tubular Epithelial Cells: From Acute Kidney Injury to Renal Fibrogenesis, Frontiers in Medicine, vol.2, 2015.

C. Ruggiero, C. M. Elks, C. Kruger, E. Cleland, K. E. Addison et al., Albumin-bound fatty acids but not albumin itself alter redox balance in tubular epithelial cells and induce a peroxide-mediated redox-sensitive apoptosis, American Journal of Physiology-Renal Physiology, vol.306, issue.8, pp.F896-F906, 2014.

M. Arici, R. Chana, A. Lewington, J. Brown, and N. J. Brunskill, Stimulation of Proximal Tubular Cell Apoptosis by Albumin-Bound Fatty Acids Mediated by Peroxisome Proliferator Activated Receptor-, Journal of the American Society of Nephrology, vol.14, issue.1, pp.17-27, 2003.

L. Thoma, ENTSCHEIDUNG AM STRAND., mAGAzin Revista intercultural e interdisciplinar, vol.14, issue.14, pp.27-28, 2003.

C. Brooks, Q. Wei, S. Cho, and Z. Dong, Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models, Journal of Clinical Investigation, vol.119, issue.5, pp.1275-1285, 2009.

S. Cho, Q. Du, S. Huang, and Z. Dong, Drp1 dephosphorylation in ATP depletion-induced mitochondrial injury and tubular cell apoptosis, American Journal of Physiology-Renal Physiology, vol.299, issue.1, pp.F199-F206, 2010.

P. Duann, E. A. Lianos, J. Ma, and P. Lin, Autophagy, Innate Immunity and Tissue Repair in Acute Kidney Injury, International Journal of Molecular Sciences, vol.17, issue.5, p.662, 2016.

Q. Wei, G. Dong, J. Chen, G. Ramesh, and Z. Dong, Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule?specific knockout mouse models, Kidney International, vol.84, issue.1, pp.138-148, 2013.

K. A. Rasbach and R. G. Schnellmann, PGC-1? over-expression promotes recovery from mitochondrial dysfunction and cell injury, Biochemical and Biophysical Research Communications, vol.355, issue.3, pp.734-739, 2007.

M. T. Tran, Z. K. Zsengeller, A. H. Berg, E. V. Khankin, M. K. Bhasin et al., PGC1? drives NAD biosynthesis linking oxidative metabolism to renal protection, Nature, vol.531, issue.7595, pp.528-532, 2016.

Y. Ishimoto and R. Inagi, Mitochondria: a therapeutic target in acute kidney injury, Nephrology Dialysis Transplantation, vol.31, issue.7, pp.1062-1069, 2015.

B. N. Chau, C. Xin, J. Hartner, S. Ren, A. P. Castano et al., MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways, Science Translational Medicine, vol.4, issue.121, pp.121ra18-121ra18, 2012.

S. G. Andersson, A. Zomorodipour, J. O. Andersson, T. Sicheritz-pontén, U. C. Alsmark et al., The genome sequence of Rickettsia prowazekii and the origin of mitochondria, Nature, vol.396, issue.6707, pp.133-140, 1998.

F. S. Sjostrand, Electron Microscopy of Mitochondria and Cytoplasmic Double Membranes: Ultra-Structure of Rod-shaped Mitochondria, Nature, vol.171, issue.4340, pp.30-31, 1953.

G. Lenaz, Mitochondria and Reactive Oxygen Species. Which Role in Physiology and Pathology?, Advances in Experimental Medicine and Biology, vol.942, pp.93-136, 2011.

S. L. Spencer and P. K. Sorger, Measuring and Modeling Apoptosis in Single Cells, Cell, vol.144, issue.6, pp.926-939, 2011.

K. S. Dimmer and L. Scorrano, (De)constructing Mitochondria: What For?, Physiology, vol.21, issue.4, pp.233-241, 2006.

C. R. Hackenbrock, B. Chazotte, and S. S. Gupte, The random collision model and a critical assessment of diffusion and collision in mitochondrial electron transport, Journal of Bioenergetics and Biomembranes, vol.18, issue.5, pp.331-368, 1986.

R. Acín-pérez, P. Fernández-silva, M. L. Peleato, A. Pérez-martos, and J. A. Enriquez, Respiratory Active Mitochondrial Supercomplexes, Molecular Cell, vol.32, issue.4, pp.529-539, 2008.

E. Lapuente-brun, R. Moreno-loshuertos, R. Acín-pérez, A. Latorre-pellicer, C. Colás et al., Supercomplex Assembly Determines Electron Flux in the Mitochondrial Electron Transport Chain, Science, vol.340, issue.6140, pp.1567-1570, 2013.

P. Mitchell, Coupling of Phosphorylation to Electron and Hydrogen Transfer by a Chemi-Osmotic type of Mechanism, Nature, vol.191, issue.4784, pp.144-148, 1961.

H. Noji and M. Yoshida, The Rotary Machine in the Cell, ATP Synthase, Journal of Biological Chemistry, vol.276, issue.3, pp.1665-1668, 2000.

S. Anderson, A. T. Bankier, B. G. Barrell, M. H. De-bruijn, A. R. Coulson et al., Sequence and organization of the human mitochondrial genome, Nature, vol.290, issue.5806, pp.457-465, 1981.

S. Dimauro, E. A. Schon, A. Munnich, R. P. Rötig, A. Chretien et al., Chinnery PF: Mitochondrial disease in adults: what's old and what's new?, Taanman JW: The mitochondrial genome: structure, transcription, translation and replication, vol.31, pp.1503-1512, 1992.

, Biochim. Biophys. Acta, vol.38, issue.5, pp.103-123, 2006.

E. Ruiz-pesini, M. T. Lott, V. T. Procaccio, J. C. Poole, M. C. Brandon et al., An enhanced MITOMAP with a global mtDNA mutational phylogeny, Nucleic Acids Research, vol.35, issue.Database, pp.D823-D828, 2007.

R. N. Lightowlers, P. F. Chinnery, D. M. Turnbull, and N. Howell, Mammalian mitochondrial genetics: heredity, heteroplasmy and disease, Trends in Genetics, vol.13, issue.11, pp.450-455, 1997.

P. F. Chinnery, N. Howell, R. M. Andrews, and D. M. Turnbull, Mitochondrial DNA analysis: polymorphisms and pathogenicity, Journal of Medical Genetics, vol.36, issue.7, pp.505-510, 1999.

R. Rossignol, B. Faustin, C. Rocher, M. Malgat, J. Mazat et al., Mitochondrial threshold effects, Biochemical Journal, vol.370, issue.3, pp.751-762, 2003.

M. Sato and K. Sato, Maternal inheritance of mitochondrial DNA, Autophagy, vol.8, issue.3, pp.424-425, 2012.

, DISCUSSION, Annals of the New York Academy of Sciences, vol.143, issue.1 Biology of th, pp.73-76, 1967.

G. S. Gorman, A. M. Schaefer, Y. Ng, N. Gomez, E. L. Blakely et al., Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease, Annals of Neurology, vol.77, issue.5, pp.753-759, 2015.

T. Bourgeron, P. Rustin, D. Chretien, M. Birch-machin, M. Bourgeois et al., Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency, Nature Genetics, vol.11, issue.2, pp.144-149, 1995.

R. N. Lightowlers, R. W. Taylor, D. M. Turnbull, A. W. El-hattab, A. M. Adesina et al., Goto Y, Nonaka I, Horai S: A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies, Mutations causing mitochondrial disease: What is new and what challenges remain, vol.349, pp.1429-1430, 1990.

S. Dimauro and E. A. Schon, Mitochondrial Respiratory-Chain Diseases, New England Journal of Medicine, vol.348, issue.26, pp.2656-2668, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00537248

Z. Wang, Z. Ying, A. Bosy-westphal, J. Zhang, B. Schautz et al., Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure, The American Journal of Clinical Nutrition, vol.92, issue.6, pp.1369-1377, 2010.

K. Wahbi, W. Bougouin, A. Béhin, T. Stojkovic, H. M. Bécane et al., Long-term cardiac prognosis and risk stratification in 260 adults presenting with mitochondrial diseases, European Heart Journal, vol.36, issue.42, pp.2886-2893, 2015.

E. Bertini and A. D’amico, Mitochondrial Encephalomyopathies and Related Syndromes: Brief Review, Endocrine Involvement in Developmental Syndromes, vol.14, pp.38-52, 2009.

C. Tranchant and M. Anheim, Fischel-Ghodsian N: Mitochondrial mutations and hearing loss: paradigm for mitochondrial genetics, J. Neuropathol. Exp. Neurol, vol.172, pp.15-19, 1998.

C. Zhu, E. I. Traboulsi, and S. Parikh, Ophthalmological findings in 74 patients with mitochondrial disease, Ophthalmic Genetics, vol.38, issue.1, pp.67-69, 2016.

T. Kadowaki, H. Kadowaki, Y. Mori, K. Tobe, R. K. Sakuta et al., A Subtype of Diabetes Mellitus Associated with a Mutation of Mitochondrial DNA, New England Journal of Medicine, vol.330, issue.14, pp.962-968, 1994.

S. Rahman, Gastrointestinal and hepatic manifestations of mitochondrial disorders, Journal of Inherited Metabolic Disease, vol.36, issue.4, pp.659-673, 2013.

. Metab and . Dis, , vol.36, pp.659-673, 2013.

C. Bodemer, A. Rotig, P. Rustin, V. Cormier, P. Niaudet et al., Hair and Skin Disorders as Signs of Mitochondrial Disease, PEDIATRICS, vol.103, issue.2, pp.428-433, 1999.

J. D. Marshall, I. Bazan, Y. Zhang, W. H. Fares, and P. J. Lee, Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both, American Journal of Physiology-Lung Cellular and Molecular Physiology, vol.314, issue.5, pp.L782-L796, 2018.

J. Finsterer and M. Frank, Haematological abnormalities in mitochondrial disorders, Singapore Medical Journal, vol.56, issue.07, pp.412-419, 2015.

J. Chow, J. Rahman, J. C. Achermann, M. T. Dattani, and S. Rahman, Mitochondrial disease and endocrine dysfunction, Nature Reviews Endocrinology, vol.13, issue.2, pp.92-104, 2016.

P. M. O'connor, RENAL OXYGEN DELIVERY: MATCHING DELIVERY TO METABOLIC DEMAND, Clinical and Experimental Pharmacology and Physiology, vol.33, issue.10, pp.961-967, 2006.

F. Emma, E. Bertini, L. Salviati, and G. Montini, Renal involvement in mitochondrial cytopathies, Pediatric Nephrology, vol.27, issue.4, pp.539-550, 2011.

F. Emma, E. Bertini, L. Salviati, and G. Montini, Renal involvement in mitochondrial cytopathies, Pediatric Nephrology, vol.27, issue.4, pp.539-550, 2011.

H. Bakis, A. Trimouille, A. Vermorel, I. Redonnet, C. Goizet et al., COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement, J. Am. Soc. Nephrol. JASN, vol.97, pp.2773-2780, 2007.

O. Hotta, C. N. Inoue, S. Miyabayashi, T. Furuta, A. Takeuchi et al., Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR) gene mutation, Kidney International, vol.59, issue.4, pp.1236-1243, 2001.

H. Mochizuki, K. Joh, H. Kawame, A. Imadachi, H. Nozaki et al., Mitochondrial encephalomyopathies preceded by de-Toni-Debré-Fanconi syndrome or focal segmental glomerulosclerosis, Clin. Nephrol, vol.46, pp.347-352, 1996.

B. Guéry, G. Choukroun, L. Noël, P. Clavel, A. Rötig et al., The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation, J. Am. Soc. Nephrol. JASN, vol.14, pp.597-601, 1995.

M. A. Martín and J. Arenas, Renal pathology in children with mitochondrial diseases, Pediatr. Nephrol. Berl. Ger, vol.20, pp.1299-1305, 2005.

P. J. Guillausseau, D. Dubois-laforgue, P. Massin, M. Laloi-michelin, C. Bellanné-chantelot et al., Heterogeneity of diabetes phenotype in patients with 3243 bp mutation of mitochondrial DNA (Maternally Inherited Diabetes and Deafness or MIDD), Diabetes & Metabolism, vol.30, issue.2, pp.181-186, 2004.

A. M. Hall, A. Vilasi, I. Garcia-perez, M. Lapsley, C. L. Alston et al., The urinary proteome and metabonome differ from normal in adults with mitochondrial disease, Kidney International, vol.87, issue.3, pp.610-622, 2015.

G. Wirthensohn and W. G. Guder, Renal substrate metabolism., Physiological Reviews, vol.66, issue.2, pp.469-497, 1986.

O. M. Sejersted, P. A. Steen, and F. Kiil, Energetics of tubular sodium reabsorption sensitive to ethacrynic acid and ouabain, American Journal of Physiology-Renal Physiology, vol.242, issue.3, pp.F254-F260, 1982.

P. Deetjen, MEASUREMENT OF METABOLISM DURING RENAL WORK, Biochemical Aspects of Renal Function, vol.12, pp.243-244, 1980.

G. Torelli, E. Milla, A. Faelli, and S. Costantini, Johns O: Is tubuloglomerular feedback a tool to prevent nephron oxygen deficiency?, Pediatr. Clin. North Am, vol.211, pp.159-167, 1966.

H. Hartmannová, L. Piherová, K. Tauchmannová, K. Kidd, P. D. Acott et al., Acadian variant of Fanconi syndrome is caused by mitochondrial respiratory chain complex I deficiency due to a non-coding mutation in complex I assembly factor NDUFAF6, Human Molecular Genetics, vol.25, issue.18, pp.4062-4079, 2016.

A. Bourdon, L. Minai, V. Serre, J. Jais, E. Sarzi et al., Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion, Nature Genetics, vol.39, issue.6, pp.776-780, 2007.

E. D. Klootwijk, M. Reichold, A. Helip-wooley, A. Tolaymat, C. Broeker et al., Mistargeting of Peroxisomal EHHADH and Inherited Renal Fanconi's Syndrome, New England Journal of Medicine, vol.370, issue.2, pp.129-138, 2014.

Y. S. Lee, H. K. Yap, B. A. Barshop, Y. S. Lee, S. Rajalingam et al., Rötig A: Deletion of the mitochondrial DNA in a case of de Toni-Debré-Fanconi syndrome and Pearson syndrome, Pediatr. Nephrol. Berl. Ger, vol.16, pp.164-168, 1994.

J. M. Shoffner, A. S. Voljavec, J. Dixon, A. Kaufman, D. C. Wallace et al., Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, Renal amino acid transport in adults with oxidative phosphorylation diseases, vol.47, pp.193-200, 1995.

M. Mimaki, H. Hatakeyama, T. Ichiyama, H. Isumi, S. Furukawa et al., Different effects of novel mtDNA G3242A and G3244A base changes adjacent to a common A3243G mutation in patients with mitochondrial disorders, Mitochondrion, vol.9, issue.2, pp.115-122, 2009.

F. H. Wilson, A. Hariri, A. Farhi, H. Zhao, K. F. Petersen et al., A Cluster of Metabolic Defects Caused by Mutation in a Mitochondrial tRNA, Science, vol.306, issue.5699, pp.1190-1194, 2004.

F. Emma, C. Pizzini, A. Tessa, S. Di-giandomenico, A. Onetti-muda et al., ?Bartter-like? phenotype in Kearns?Sayre syndrome, Pediatric Nephrology, vol.21, issue.3, pp.355-360, 2005.

T. M. Connor, S. Hoer, A. Mallett, D. P. Gale, A. Gomez-duran et al., Mutations in mitochondrial DNA causing tubulointerstitial kidney disease, PLOS Genetics, vol.13, issue.3, p.e1006620, 2017.

M. Tabebi, E. Mkaouar-rebai, M. Mnif, F. Kallabi, A. Ben-mahmoud et al., A novel mutation MT-COIII m.9267G>C and MT-COI m.5913G>A mutation in mitochondrial genes in a Tunisian family with maternally inherited diabetes and deafness (MIDD) associated with sever nephropathy, Biochemical and Biophysical Research Communications, vol.459, issue.3, pp.353-360, 2015.

V. D'agati, Pathobiology of focal segmental glomerulosclerosis, Current Opinion in Nephrology and Hypertension, vol.21, issue.3, pp.243-250, 2012.

J. A. Jefferson, C. E. Alpers, and S. J. Shankland, Podocyte Biology for the Bedside, American Journal of Kidney Diseases, vol.58, issue.5, pp.835-845, 2011.

T. Imasawa and R. Rossignol, Podocyte energy metabolism and glomerular diseases, The International Journal of Biochemistry & Cell Biology, vol.45, issue.9, pp.2109-2118, 2013.

S. Güçer, B. Talim, E. A?an, P. Korkusuz, S. Ozen et al., Focal segmental glomerulosclerosis associated with mitochondrial cytopathy: report of two cases with special emphasis on podocytes, Pediatr. Dev. Pathol. Off. J. Soc. Pediatr. Pathol. Paediatr. Pathol. Soc, vol.8, pp.710-717, 2005.

C. Quinzii, A. Naini, L. Salviati, E. Trevisson, P. Navas et al., A Mutation in Para-Hydroxybenzoate-Polyprenyl Transferase (COQ2) Causes Primary Coenzyme Q10 Deficiency, The American Journal of Human Genetics, vol.78, issue.2, pp.345-349, 2006.

G. Montini, C. Malaventura, and L. Salviati, Early Coenzyme Q10 Supplementation in Primary Coenzyme Q10 Deficiency, New England Journal of Medicine, vol.358, issue.26, pp.2849-2850, 2008.

J. Mollet, I. Giurgea, D. Schlemmer, G. Dallner, D. Chretien et al., Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders, Journal of Clinical Investigation, vol.117, issue.3, pp.765-772, 2007.

R. B. Vega, J. M. Huss, D. P. Kelly, L. C. López, M. Schuelke et al., The coactivator PGC-1 cooperates with peroxisome proliferatoractivated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes, Am. J. Hum. Genet, vol.20, pp.1125-1129, 2006.

S. Ashraf, H. Y. Gee, S. Woerner, L. X. Xie, V. Vega-warner et al., ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption, Journal of Clinical Investigation, vol.123, issue.12, pp.5179-5189, 2013.

. Engl, Antignac C: Genetic models: clues for understanding the pathogenesis of idiopathic nephrotic syndrome, Lancet Lond. Engl, vol.37, pp.1287-1295, 2002.

M. W. Becher, M. L. Wills, W. W. Noll, O. Hurko, and D. L. Price, Kearns-Sayre syndrome with features of Pearson's marrow-pancreas syndrome and a novel 2905-base pair mitochondrial DNA deletion, Human Pathology, vol.30, issue.5, pp.577-581, 1999.

J. J. Jansen, J. A. Maassen, F. J. Van-der-woude, H. A. Lemmink, J. M. Van-den-ouweland et al., Mutation in mitochondrial tRNA(Leu(UUR)) gene associated with progressive kidney disease, J. Am. Soc. Nephrol. JASN, vol.8, pp.1118-1124, 1997.

M. S. Damian, A. Hertel, P. Seibel, H. Reichmann, G. Bachmann et al., Follow-Up in Carriers of the ?MELAS? Mutation without Strokes, European Neurology, vol.39, issue.1, pp.9-15, 1998.

L. M. Doleris, G. S. Hill, P. Chedin, D. Nochy, C. Bellanne-chantelot et al., Focal segmental glomerulosclerosis associated with mitochondrial cytopathy, Kidney International, vol.58, issue.5, pp.1851-1858, 2000.

F. Emma, G. Montini, S. M. Parikh, and L. Salviati, Mitochondrial dysfunction in inherited renal disease and acute kidney injury, Nature Reviews Nephrology, vol.12, issue.5, pp.267-280, 2016.

F. Kurogouchi, T. Oguchi, E. Mawatari, S. Yamaura, K. Hora et al., A Case of Mitochondrial Cytopathy with a Typical Point Mutation for MELAS, Presenting with Severe Focal-Segmental Glomerulosclerosis as MainClinical Manifesta tion, American Journal of Nephrology, vol.18, issue.6, pp.551-556, 1998.

H. Fujii, Y. Mori, K. Kayamori, T. Igari, E. Ito et al., A familial case of mitochondrial disease resembling Alport syndrome, Clinical and Experimental Nephrology, vol.12, issue.2, pp.159-163, 2008.

K. Sugai, H. Ueda, K. Morimoto, M. Tanaka, D. Takahashi et al., Maternally inherited diabetes and deafness complicated by mesangial galactose-deficient IgA1 deposits: a case report, BMC Nephrology, vol.19, issue.1, 2018.

H. I. Cheong, J. H. Chae, J. S. Kim, H. W. Park, I. S. Ha et al., Hereditary glomerulopathy associated with a mitochondrial tRNA Leu gene mutation, Pediatric Nephrology, vol.13, issue.6, pp.477-480, 1999.

K. Lim, D. Steele, A. Fenves, R. Thadhani, E. Heher et al., Focal segmental glomerulosclerosis associated with mitochondrial disease, Clinical Nephrology ? Case Studies, vol.5, issue.1, pp.20-25, 2017.

P. Massin, D. Dubois-laforgue, T. Meas, M. Laloi-michelin, H. Gin et al., Retinal and renal complications in patients with a mutation of mitochondrial DNA at position 3,243 (maternally inherited diabetes and deafness). A case?control study, Diabetologia, vol.51, issue.9, pp.1664-1670, 2008.

T. Imasawa, M. Tanaka, Y. Yamaguchi, T. Nakazato, H. Kitamura et al., 7501 T > A mitochondrial DNA variant in a patient with glomerulosclerosis, Renal Failure, vol.36, issue.9, pp.1461-1465, 2014.

S. Nakamura, M. Yoshinari, Y. Doi, H. Yoshizumi, R. Katafuchi et al., Renal complications in patients with diabetes mellitus associated with an A to G mutation of mitochondrial DNA at the 3243 position of leucine tRNA, Diabetes Research and Clinical Practice, vol.44, issue.3, pp.183-189, 1999.

A. Motoda, T. Kurashige, T. Sugiura, T. Nakamura, T. Yamawaki et al., A case of MELAS with G13513A mutation presenting with chronic kidney disease long before stroke-like episodes, Rinsho Shinkeigaku, vol.53, issue.6, pp.446-451, 2013.

, Editor?s Note, Rinsho Shinkeigaku, vol.53, issue.8, pp.689-689, 2013.

M. M. Lowik, F. A. Hol, E. J. Steenbergen, J. F. Wetzels, and L. P. Van-den-heuvel, Mitochondrial tRNALeu(UUR) mutation in a patient with steroid-resistant nephrotic syndrome and focal segmental glomerulosclerosis, Nephrology Dialysis Transplantation, vol.20, issue.2, pp.336-341, 2004.

K. Yamagata, K. Muro, J. Usui, M. Hagiwara, H. Kai et al., Mitochondrial DNA Mutations in Focal Segmental Glomerulosclerosis Lesions, Journal of the American Society of Nephrology, vol.13, issue.7, pp.1816-1823, 2002.

K. Narumi, E. Mishima, Y. Akiyama, T. Matsuhashi, T. Nakamichi et al., Focal Segmental Glomerulosclerosis Associated with Chronic Progressive External Ophthalmoplegia and Mitochondrial DNA A3243G Mutation, Nephron, vol.138, issue.3, pp.243-248, 2017.

A. Seidowsky, M. Hoffmann, F. Glowacki, C. Dhaenens, J. Devaux et al., Renal involvement in MELAS syndrome – a series of 5 cases and review of the literature, Clinical Nephrology, vol.80, issue.12, pp.456-463, 2013.

S. Parikh, A. Goldstein, M. K. Koenig, F. Scaglia, G. M. Enns et al., Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society, Genetics in Medicine, vol.17, issue.9, pp.689-701, 2014.

E. Morava, L. Van-den-heuvel, F. Hol, M. C. De-vries, M. Hogeveen et al., Mitochondrial disease criteria: Diagnostic applications in children, Neurology, vol.67, issue.10, pp.1823-1826, 2006.

A. C. Baxmann, M. S. Ahmed, N. C. Marques, V. B. Menon, A. B. Pereira et al., Influence of Muscle Mass and Physical Activity on Serum and Urinary Creatinine and Serum Cystatin C, Clinical Journal of the American Society of Nephrology, vol.3, issue.2, pp.348-354, 2008.

P. E. Stevens, A. Levin, and K. Disease, Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline, Annals of Internal Medicine, vol.158, issue.11, p.825, 2013.

S. Dimauro, E. A. Schon, V. Carelli, and M. Hirano, The clinical maze of mitochondrial neurology, Nature Reviews Neurology, vol.9, issue.8, pp.429-444, 2013.

P. Niaudet and A. Rötig, The kidney in mitochondrial cytopathies, Kidney International, vol.51, issue.4, pp.1000-1007, 1997.

K. E. D?aco, M. Manno, C. Clarke, J. Ganesh, K. E. Meyers et al., Mitochondrial tRNAPhe mutation as a cause of end-stage renal disease in childhood, Pediatric Nephrology, vol.28, issue.3, pp.515-519, 2012.

C. Y. Tzen, J. D. Tsai, T. Y. Wu, B. F. Chen, M. F. Chen et al., Tubulointerstitial nephritis associated with a novel mitochondrial point mutation, Kidney International, vol.59, issue.3, pp.846-854, 2001.

J. Finsterer, Cerebral imaging in adult mitochondrial disorders, Journal of the Neurological Sciences, vol.404, pp.29-35, 2019.

E. Wilichowski, P. J. Pouwels, J. Frahm, and F. Hanefeld, Quantitative Proton Magnetic Resonance Spectroscopy of Cerebral Metabolic Disturbances in Patients with MELAS, Neuropediatrics, vol.30, issue.05, pp.256-263, 1999.

C. Sundaram, A. K. Meena, M. S. Uppin, P. Govindaraj, A. Vanniarajan et al., Contribution of muscle biopsy and genetics to the diagnosis of chronic progressive external opthalmoplegia of mitochondrial origin, Journal of Clinical Neuroscience, vol.18, issue.4, pp.535-538, 2011.

P. Rustin, D. Chretien, T. Bourgeron, B. Gérard, A. Rötig et al., Biochemical and molecular investigations in respiratory chain deficiencies, Clinica Chimica Acta, vol.228, issue.1, pp.35-51, 1994.

A. Kobayashi, Y. Goto, M. Nagata, and Y. Yamaguchi, Granular Swollen Epithelial Cells: A Histologic and Diagnostic Marker for Mitochondrial Nephropathy, The American Journal of Surgical Pathology, vol.34, issue.2, pp.262-270, 2010.

T. Imasawa, M. Tanaka, N. Maruyama, T. Kawaguchi, Y. Yamaguchi et al., Pathological similarities between low birth weight-related nephropathy and nephropathy associated with mitochondrial cytopathy, Diagnostic Pathology, vol.9, issue.1, p.181, 2014.

A. Gupta, I. Colmenero, N. K. Ragge, E. L. Blakely, L. He et al., Compound heterozygous RMND1 gene variants associated with chronic kidney disease, dilated cardiomyopathy and neurological involvement: a case report, BMC Research Notes, vol.9, issue.1, p.325, 2016.

M. Hirano, K. Konishi, N. Arata, M. Iyori, T. Saruta et al., Renal Complications in a Patient with A-to-G Mutation of Mitochondrial DNA at the 3243 Position of Leucine tRNA., Internal Medicine, vol.41, issue.2, pp.113-118, 2002.

B. A. Payne, K. Gardner, J. Coxhead, and P. F. Chinnery, Deep Resequencing of Mitochondrial DNA, Methods in Molecular Biology, vol.1264, pp.59-66, 2015.

H. Cui, F. Li, D. Chen, G. Wang, C. K. Truong et al., Comprehensive next-generation sequence analyses of the entire mitochondrial genome reveal new insights into the molecular diagnosis of mitochondrial DNA disorders, Genetics in Medicine, vol.15, issue.5, pp.388-394, 2013.

P. De-laat, S. Koene, L. P. Van-den-heuvel, R. J. Rodenburg, M. C. Janssen et al., Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation, Journal of Inherited Metabolic Disease, vol.35, issue.6, pp.1059-1069, 2012.

. >-g-mutation, J. Inherit. Metab. Dis, vol.35, pp.1059-1069, 2012.

R. W. Taylor, A. Pyle, H. Griffin, E. L. Blakely, J. Duff et al., Use of Whole-Exome Sequencing to Determine the Genetic Basis of Multiple Mitochondrial Respiratory Chain Complex Deficiencies, JAMA, vol.312, issue.1, p.68, 2014.

P. F. Chinnery, S. Dimauro, S. Shanske, E. A. Schon, M. Zeviani et al., Risk of developing a mitochondrial DNA deletion disorder, The Lancet, vol.364, issue.9434, pp.592-596, 2004.

S. Dimauro, M. Mancuso, and A. Naini, Mitochondrial Encephalomyopathies, Mitochondrial Pathogenesis, pp.232-245, 2004.

S. Dimauro, M. Mancuso, and A. Naini, Mitochondrial Encephalomyopathies: Therapeutic Approach, Annals of the New York Academy of Sciences, vol.1011, issue.1, pp.232-245, 2004.

M. Hirano, V. Emmanuele, and C. M. Quinzii, Emerging therapies for mitochondrial diseases, Essays in Biochemistry, vol.62, issue.3, pp.467-481, 2018.

G. Pfeffer, K. Majamaa, D. M. Turnbull, D. Thorburn, and P. F. Chinnery, Treatment for mitochondrial disorders, Cochrane Database of Systematic Reviews, vol.004426, 2012.

T. Taivassalo, E. A. Shoubridge, J. Chen, N. G. Kennaway, S. Dimauro et al., Aerobic conditioning in patients with mitochondrial myopathies: Physiological, biochemical, and genetic effects, Annals of Neurology, vol.50, issue.2, pp.133-141, 2001.

S. C. Johnson, M. E. Yanos, E. Kayser, A. Quintana, M. Sangesland et al., mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome, Science, vol.342, issue.6165, pp.1524-1528, 2013.

S. E. Siegmund, H. Yang, R. Sharma, M. Javors, O. Skinner et al., Low-dose rapamycin extends lifespan in a mouse model of mtDNA depletion syndrome, Human Molecular Genetics, vol.26, issue.23, pp.4588-4605, 2017.

S. C. Johnson, F. Martinez, A. Bitto, B. Gonzalez, C. Tazaerslan et al., mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases, Kidney International, vol.95, issue.2, pp.455-466, 2019.

X. Wan, H. Pei, M. Zhao, S. Yang, W. Hu et al., Efficacy and Safety of rAAV2-ND4 Treatment for Leber?s Hereditary Optic Neuropathy, Scientific Reports, vol.6, issue.1, p.21587, 2016.

S. R. Bacman, S. L. Williams, M. Pinto, S. Peralta, and C. T. Moraes, Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs, Nature Medicine, vol.19, issue.9, pp.1111-1113, 2013.

E. Perli, C. Giordano, A. Pisano, A. Montanari, A. F. Campese et al., The isolated carboxy?terminal domain of human mitochondrial leucyl? tRNA synthetase rescues the pathological phenotype of mitochondrial tRNA mutations in human cells, EMBO Molecular Medicine, vol.6, issue.2, pp.169-182, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-01168181

. Hugo-bakis, . Aurélien-trimouille, . Agathe-vermorel, . Isabelle-redonnet, . Cyril-goizet et al., Author response for "Adult onset tubulo?interstitial nephropathy in MT?ND5?related phenotypes", Transplantation, vol.10, 2019.

S. Yamashita, A. J. Shah, S. Mahida, J. Sellal, B. Berte et al., Body Surface Mapping to Guide Atrial Fibrillation Ablation, Arrhythmia & Electrophysiology Review, vol.4, issue.3, p.172, 2015.

F. Bordeaux, , vol.7

S. Yamashita, A. J. Shah, S. Mahida, J. Sellal, B. Berte et al., Body Surface Mapping to Guide Atrial Fibrillation Ablation, Arrhythmia & Electrophysiology Review, vol.4, issue.3, p.172, 2015.

. Bordeaux, Institut des Maladies Neurodégénératives, F-33000 Bordeaux, France ; 13 CNRS, Institut des Maladies Neurodégénératives, F-33000 Bordeaux References

S. G. Andersson, A. Zomorodipour, J. O. Andersson, T. Sicheritz-pontén, U. C. Alsmark et al., The genome sequence of Rickettsia prowazekii and the origin of mitochondria, Nature, vol.396, issue.6707, pp.133-140, 1998.

G. Lenaz, Mitochondria and Reactive Oxygen Species. Which Role in Physiology and Pathology?, Advances in Experimental Medicine and Biology, pp.93-136, 2011.

A. I. Voskoboev and V. A. Averin, Purification of thiamine-binding protein of rat erythrocytes by affinity chromatography, Bulletin of Experimental Biology and Medicine, vol.93, issue.1, pp.136-137, 1982.

D. R. Green and J. C. Reed, Mitochondria and apoptosis, vol.281, pp.1309-1312, 1998.

D. Green and . Mitochondrion, The Mitochondrion, Scientific American, vol.210, issue.1, pp.63-74, 1964.

P. Mitchell, Coupling of Phosphorylation to Electron and Hydrogen Transfer by a Chemi-Osmotic type of Mechanism, Nature, vol.191, issue.4784, pp.144-148, 1961.

S. Anderson, A. T. Bankier, B. G. Barrell, M. H. De-bruijn, A. R. Coulson et al., Sequence and organization of the human mitochondrial genome, Nature, vol.290, issue.5806, pp.457-465, 1981.

S. E. Calvo and V. K. Mootha, The Mitochondrial Proteome and Human Disease, Annual Review of Genomics and Human Genetics, vol.11, issue.1, pp.25-44, 2010.

G. Attardi and G. Schatz, Biogenesis of Mitochondria, Annual Review of Cell Biology, vol.4, issue.1, pp.289-331, 1988.

S. Dimauro, E. A. Schon, A. Munnich, R. P. Rötig, A. Chretien et al., Chinnery PF: Mitochondrial disease in adults: what's old and what's new?, J. Inherit. Metab. Dis, vol.31, pp.1503-1512, 1992.

S. Sallevelt, C. De-die-smulders, A. Hendrickx, D. Hellebrekers, I. De-coo et al., Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease, J. Med. Genet, vol.54, pp.753-759, 2015.

K. Neveling, I. Feenstra, C. Gilissen, L. H. Hoefsloot, E. Kamsteeg et al., A Post-Hoc Comparison of the Utility of Sanger Sequencing and Exome Sequencing for the Diagnosis of Heterogeneous Diseases, Human Mutation, vol.34, issue.12, pp.1721-1726, 2013.

S. Parikh, A. Goldstein, M. K. Koenig, F. Scaglia, G. M. Enns et al., Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society, Genetics in Medicine, vol.17, issue.9, pp.689-701, 2014.

C. Greene, A. L. Gropman, R. Haas, M. Hirano, P. Morgan et al., Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society, Genet. Med. Off. J. Am. Coll. Med. Genet, vol.17, pp.689-701, 2015.

R. W. Taylor, A. Pyle, H. Griffin, E. L. Blakely, J. Duff et al., Use of Whole-Exome Sequencing to Determine the Genetic Basis of Multiple Mitochondrial Respiratory Chain Complex Deficiencies, JAMA, vol.312, issue.1, p.68, 2014.

S. Dimauro and E. A. Schon, Mitochondrial Respiratory-Chain Diseases, New England Journal of Medicine, vol.348, issue.26, pp.2656-2668, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00537248

Z. Wang, Z. Ying, A. Bosy-westphal, J. Zhang, B. Schautz et al., Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure, The American Journal of Clinical Nutrition, vol.92, issue.6, pp.1369-1377, 2010.

A. M. Hall, A. Vilasi, I. Garcia-perez, M. Lapsley, C. L. Alston et al., The urinary proteome and metabonome differ from normal in adults with mitochondrial disease, Kidney International, vol.87, issue.3, pp.610-622, 2015.

F. Emma, G. Montini, S. M. Parikh, and L. Salviati, Mitochondrial dysfunction in inherited renal disease and acute kidney injury, Nature Reviews Nephrology, vol.12, issue.5, pp.267-280, 2016.

B. Guéry, G. Choukroun, L. Noël, P. Clavel, A. Rötig et al., The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation, J. Am. Soc. Nephrol. JASN, vol.14, pp.628-633, 2020.

J. J. Jansen, J. A. Maassen, F. J. Van-der-woude, H. A. Lemmink, J. M. Van-den-ouweland et al., Mutation in mitochondrial tRNA(Leu(UUR)) gene associated with progressive kidney disease, J. Am. Soc. Nephrol. JASN, vol.8, pp.721-728, 2001.

T. M. Connor, S. Hoer, A. Mallett, D. P. Gale, A. Gomez-duran et al., Mutations in mitochondrial DNA causing tubulointerstitial kidney disease, PLOS Genetics, vol.13, issue.3, p.e1006620, 2017.

M. Tabebi, E. Mkaouar-rebai, M. Mnif, F. Kallabi, A. Ben-mahmoud et al., A novel mutation MT-COIII m.9267G>C and MT-COI m.5913G>A mutation in mitochondrial genes in a Tunisian family with maternally inherited diabetes and deafness (MIDD) associated with sever nephropathy, Biochemical and Biophysical Research Communications, vol.459, issue.3, pp.353-360, 2015.

M. S. Damian, A. Hertel, P. Seibel, H. Reichmann, G. Bachmann et al., Kearns-Sayre syndrome with features of Pearson's marrow-pancreas syndrome and a novel 2905-base pair mitochondrial DNA deletion, Eur. Neurol, vol.39, pp.1101-1107, 1995.

O. Hotta, C. N. Inoue, S. Miyabayashi, T. Furuta, A. Takeuchi et al., Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR) gene mutation, Kidney International, vol.59, issue.4, pp.1236-1243, 2001.

S. Dimauro, M. Mancuso, and A. Naini, Mitochondrial Encephalomyopathies, Mitochondrial Pathogenesis, pp.232-245, 2004.

Y. Acad and . Sci, CKD Evaluation and Management -KDIGO, vol.1011, p.36, 2004.

A. S. Levey, L. A. Stevens, C. H. Schmid, Y. (. Zhang, A. F. Castro et al., A New Equation to Estimate Glomerular Filtration Rate, Annals of Internal Medicine, vol.150, issue.9, p.604, 2009.

F. Lente, T. Greene, J. Coresh, and . Ckd-epi, Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate, Adv. Chronic Kidney Dis, vol.150, pp.57-63, 2009.

C. Roufosse, N. Simmonds, M. Clahsen-van-groningen, M. Haas, K. J. Henriksen et al., ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC), Transplantation, vol.102, pp.2733-2779, 2014.

K. Wahbi, W. Bougouin, A. Béhin, T. Stojkovic, H. M. Bécane et al., Long-term cardiac prognosis and risk stratification in 260 adults presenting with mitochondrial diseases, European Heart Journal, vol.36, issue.42, pp.2886-2893, 2015.

F. Debray, G. A. Mitchell, P. Allard, B. H. Robinson, J. A. Hanley et al., Diagnostic Accuracy of Blood Lactate-to-Pyruvate Molar Ratio in the Differential Diagnosis of Congenital Lactic Acidosis, Clinical Chemistry, vol.53, issue.5, pp.916-921, 2007.

P. Massin, D. Dubois-laforgue, T. Meas, M. Laloi-michelin, H. Gin et al., Retinal and renal complications in patients with a mutation of mitochondrial DNA at position 3,243 (maternally inherited diabetes and deafness). A case?control study, Diabetologia, vol.51, issue.9, pp.1664-1670, 2008.

E. Martín-hernández, M. T. García-silva, J. Vara, Y. Campos, A. Cabello et al., Renal pathology in children with mitochondrial diseases, Pediatric Nephrology, vol.20, issue.9, pp.1299-1305, 2005.

I. J. Holt, A. E. Harding, and J. A. Morgan-hughes, Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies, Nature, vol.331, issue.6158, pp.717-719, 1988.

D. C. Wallace, G. Singh, M. T. Lott, J. A. Hodge, T. G. Schurr et al., Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy, Science, vol.242, issue.4884, pp.1427-1430, 1988.

P. E. Stevens, A. Levin, and K. Disease, Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline, Annals of Internal Medicine, vol.158, issue.11, p.825, 2013.

T. Taivassalo, E. A. Shoubridge, J. Chen, N. G. Kennaway, S. Dimauro et al., Aerobic conditioning in patients with mitochondrial myopathies: Physiological, biochemical, and genetic effects, Annals of Neurology, vol.50, issue.2, pp.133-141, 2001.

, Ann. Neurol, vol.50, issue.2, pp.133-141, 2001.

S. Parikh, A. Karaa, A. Goldstein, Y. S. Ng, G. Gorman et al., Solid organ transplantation in primary mitochondrial disease: Proceed with caution, Molecular Genetics and Metabolism, vol.118, issue.3, pp.178-184, 2016.

S. C. Johnson, F. Martinez, A. Bitto, B. Gonzalez, C. Tazaerslan et al., mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases, Kidney International, vol.95, issue.2, pp.455-466, 2019.

T. Imasawa, M. Tanaka, N. Maruyama, T. Kawaguchi, Y. Yamaguchi et al., Pathological similarities between low birth weight-related nephropathy and nephropathy associated with mitochondrial cytopathy, Diagnostic Pathology, vol.9, issue.1, p.181, 2014.

H. Fujii, Y. Mori, K. Kayamori, T. Igari, E. Ito et al., A familial case of mitochondrial disease resembling Alport syndrome, Clinical and Experimental Nephrology, vol.12, issue.2, pp.159-163, 2008.

P. A. Sarafidis, S. Li, S. Chen, A. J. Collins, W. W. Brown et al., Experimental Renovascular Disease Induces Endothelial Cell Mitochondrial Damage and Impairs Endothelium-Dependent Relaxation of Renal Artery Segments, Am. J. Hypertens, vol.121, pp.765-774, 2008.

M. Su, A. Dhoopun, Y. Yuan, S. Huang, C. Zhu et al., Eirin A: Renovascular disease induces mitochondrial damage in swine scattered tubular cells, Am. J. Physiol. Renal Physiol, vol.305, pp.1142-1153, 2013.

X. C. Li, X. Zhou, and J. L. Zhuo, Evidence for a Physiological Mitochondrial Angiotensin II System in the Kidney Proximal Tubules, Hypertension, vol.76, issue.1, pp.121-132, 2020.

Y. U. Ding, B. Xia, J. Yu, J. Leng, and J. Huang, Mitochondrial DNA mutations and essential hypertension (Review), International Journal of Molecular Medicine, vol.32, issue.4, pp.768-774, 2013.

C. Liu, Q. Yang, S. Hwang, F. Sun, A. D. Johnson et al., Association of Genetic Variation in the Mitochondrial Genome With Blood Pressure and Metabolic Traits, Hypertension, vol.60, issue.4, pp.949-956, 2012.

D. Marsden, W. L. Nyhan, and B. A. Barshop, Creatine kinase and uric acid: early warning for metabolic imbalance resulting from disorders of fatty acid oxidation, European Journal of Pediatrics, vol.160, issue.10, pp.599-602, 2001.

M. Chonchol, M. G. Shlipak, R. Katz, M. J. Sarnak, A. B. Newman et al., Relationship of Uric Acid With Progression of Kidney Disease, American Journal of Kidney Diseases, vol.50, issue.2, pp.239-247, 2007.

R. Belostotsky, E. Ben-shalom, C. Rinat, R. Becker-cohen, S. Feinstein et al., Mutations in the Mitochondrial Seryl-tRNA Synthetase Cause Hyperuricemia, Pulmonary Hypertension, Renal Failure in Infancy and Alkalosis, HUPRA Syndrome, The American Journal of Human Genetics, vol.88, issue.2, pp.193-200, 2011.

Q. Hong, K. Qi, Z. Feng, Z. Huang, S. Cui et al., Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations, Nephron Exp. Nephrol, vol.51, pp.71-78, 2012.

R. P. Obermayr, C. Temml, G. Gutjahr, M. Knechtelsdorfer, R. Oberbauer et al., Elevated uric acid increases the risk for kidney disease, Hyperuricemia-induced inflammasome and kidney diseases, vol.19, pp.890-896, 2008.

B. A. Payne, K. Gardner, J. Coxhead, and P. F. Chinnery, Deep Resequencing of Mitochondrial DNA, Methods in Molecular Biology, vol.1264, pp.59-66, 2015.

S. Shanske, J. Pancrudo, P. Kaufmann, K. Engelstad, S. Jhung et al., Varying loads of the mitochondrial DNA A3243G mutation in different tissues: Implications for diagnosis, American Journal of Medical Genetics, vol.130A, issue.2, pp.134-137, 2004.

A. Fayssoil, P. Laforêt, W. Bougouin, C. Jardel, A. Lombès et al., Prediction of long-term prognosis by heteroplasmy levels of the m.3243A>G mutation in patients with the mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome, European Journal of Neurology, vol.24, issue.2, pp.255-261, 2016.

, Figure 1?source data 1. Histopathological analysis (related to Figure 1D).

A. , Masson Trichrome Staining Method, 2020.

J. Choi, S. Nam, and J. Cha, Invasion of Calponin-positive Glomerular Parietal Epithelial Cells into Glomerular Tuft Is Related to the Development of Glomerulosclerosis, Applied Microscopy, vol.44, issue.4, pp.117-122, 2014.

B. , Table S1: Supplemental tables, pp.p-value

, Table 3: Outcomes expressed as median and interquartile range (IQR) (Wilcoxon?Mann?Whitney test)., CPK: creatine phosphor-kinase / GFR: glomerular filtration rate / IQR: interquartile range. *:Chi-2 or Wilcoxon test